KHB: Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024

Shanghai Kehua Bio-Engineering Co.,Ltd reported earnings results for the nine months ended September 30, 2024. For the nine months, the company reported sales was CNY 1,350.22 million compared to CNY 1,904.22 million a year ago. Revenue was CNY 1,350.22 million compared to CNY 1,904.22 million a year ago. Net loss was CNY 122.14 million compared to CNY 19.95 million a year ago. Basic loss per share from continuing operations was CNY 0.2413 compared to CNY 0.0388 a year ago. Diluted loss per share from continuing operations was CNY 0.2413 compared to CNY 0.0388 a year ago.